KLS Martin, LP – Trademark Portfolio
Entity Type: 13
KLS Martin, LP holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 6 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include RESORB-X, PURE PECTUS, and CRANIO SCULPT. The owner is based in Jacksonville, FL.
11201 St. Johns Industrial Parkway South
Jacksonville, FL 32246
Showing of trademarks Trademarks
Trademark Classifications
KLS Martin, LP's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does KLS Martin, LP have?
KLS Martin, LP has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending, 2 abandoned, 1 cancelled.
What trademark classes does KLS Martin, LP file in?
KLS Martin, LP files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are KLS Martin, LP's most well-known trademarks?
KLS Martin, LP's registered trademark portfolio includes well-known marks such as RESORB-X, PURE PECTUS, and CRANIO SCULPT. These are among 3 currently registered trademarks in the portfolio.
What is KLS Martin, LP's trademark registration success rate?
KLS Martin, LP has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 1 application is pending review.